Abstract: BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia

Go to website – http://pipelinereview.com/index.php/2017012563690/Small-Molecules/BeiGene-Initiates-Global-Phase-III-Trial-of-the-BTK-Inhibitor-BGB-3111-in-Waldenstroms-Macroglobulinemia.html

PDF – BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia | Small Molecules | News Channels

BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s… Continue reading →